Zobrazeno 1 - 10
of 23
pro vyhledávání: '"M Wouter Dercksen"'
Autor:
Stefanie de Groot, Hanno Pijl, Ayoub Charehbili, Saskia van de Ven, Vincent T. H. B. M. Smit, Elma Meershoek-Klein Kranenbarg, Joan B. Heijns, Laurence J. C. van Warmerdam, Lonneke W. Kessels, M. Wouter Dercksen, Manon J. A. E. Pepels, Hanneke W. M. van Laarhoven, Birgit E. P. J. Vriens, Hein Putter, Marta Fiocco, Gerrit-Jan Liefers, Jacobus J. M. van der Hoeven, Johan W. R. Nortier, Judith R. Kroep, on behalf of the Dutch Breast Cancer Research Group
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-9 (2019)
Abstract Background Adjuvant bisphosphonates are associated with improved breast cancer survival in postmenopausal patients. Addition of zoledronic acid (ZA) to neoadjuvant chemotherapy did not improve pathological complete response in the phase III
Externí odkaz:
https://doaj.org/article/a99967db5d734f59a7bddc08f547d2ce
Autor:
Marissa Meegdes, Khava I. E. Ibragimova, Dorien J. A. Lobbezoo, Ingeborg J. H. Vriens, Loes F. S. Kooreman, Frans L. G. Erdkamp, M. Wouter Dercksen, Birgit E. P. J. Vriens, Kirsten N. A. Aaldering, Manon J. A. E. Pepels, Linda M. H. van de Winkel, Jolien Tol, Joan B. Heijns, Agnes J. van de Wouw, Natascha A. J. B. Peters, Ananda Hochstenbach-Waelen, Marjolein L. Smidt, Sandra M. E. Geurts, Vivianne C. G. Tjan-Heijnen
Publikováno v:
Breast Cancer Research and Treatment, 192(2), 331-342. Springer, Cham
Purpose The hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) are the main parameters in guiding systemic treatment choices in breast cancer, but can change during the disease course. This study aims to evaluate the biopsy rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15a5e909880f3c106d7fac4396b47579
https://doi.org/10.1007/s10549-021-06472-5
https://doi.org/10.1007/s10549-021-06472-5
Autor:
Sandra M. E. Geurts, Vivianne C. G. Tjan-Heijnen, Bram Ramaekers, M. Wouter Dercksen, Roel J.W. van Kampen, Agnes J. van de Wouw, Dorien J.A. Lobbezoo, Manuela A. Joore, Anouk K. M. Claessens, Maaike de Boer
Publikováno v:
Quality of Life Research, 29(12), 3363-3374. Springer, Cham
Quality of Life Research
Quality of Life Research
Purpose We aimed to evaluate quality of life (QoL) using the European Quality of Life Five-Dimensions questionnaire (EQ-5D-3L) in a real-world cohort of Dutch advanced breast cancer (ABC) patients. Secondary, we reported differences in QoL between su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bdd9fafb0cc8681c1a2e674db29638c
https://cris.maastrichtuniversity.nl/en/publications/9f4bbcac-757c-4aa4-8d52-5f426419d3a2
https://cris.maastrichtuniversity.nl/en/publications/9f4bbcac-757c-4aa4-8d52-5f426419d3a2
Autor:
Sandra M. E. Geurts, Maaike de Boer, M. Wouter Dercksen, Dominique. J. P. Tilli, Vivianne C. G. Tjan-Heijnen, Manon J. Pepels, Khava I.E. Ibragimova, Frans L. G. Erdkamp, Marien O den Boer, Birgit Epj Vriens
Publikováno v:
Cancer Research. 80:P2-08
Background The aim of this study was to determine the subtype conversion rate and the initial systemic treatment choices by subtype for patients diagnosed with advanced breast cancer since 2007 who were included in the SONABRE Registry. Patients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8382c1fdd3dc0a31895fb397d65fd8db
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-06
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-06
Autor:
Sandra M. E. Geurts, Marien O den Boer, Khava I.E. Ibragimova, Maaike de Boer, Frans L. G. Erdkamp, Birgit Epj Vriens, Vivianne C. G. Tjan-Heijnen, M. Wouter Dercksen, Manon J. Pepels, Nathalie J. A. Teeuwen
Publikováno v:
Cancer Research. 80:P1-19
Background Previously, we reported that patients with HR+/HER2+ advanced breast cancer diagnosed in 2007-2009 had a better overall survival (OS) than patients with HR-/HER2+ advanced breast cancer (SONABRE Registry, Lobbezoo et al. BCRT 2013). This d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d47a1234dd53235804586280b9f76a84
https://doi.org/10.1158/1538-7445.sabcs19-p1-19-34
https://doi.org/10.1158/1538-7445.sabcs19-p1-19-34
Autor:
Gerlof D. Valk, Margot E T Tesselaar, Koert F. D. Kuhlmann, Gerrit A. Meijer, Paul Roepman, M Wouter Dercksen, José G van den Berg, Kris G. Samsom, Liudmila L. Kodach, Sonja Levy, Wieke H M Verbeek, Neeltje Steeghs, Linde M. van Veenendaal
Publikováno v:
HistopathologyReferences. 78(4)
Aims To investigate the clinicopathological significance of driver mutations in metastatic well-differentiated small intestine neuroendocrine tumours (SI-NETs). Methods and results Whole genome sequencing (WGS) of 35 metastatic SI-NETs and next-gener
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9280554e242d09c4eb4e1881ec459b95
https://pubmed.ncbi.nlm.nih.gov/32931025
https://pubmed.ncbi.nlm.nih.gov/32931025
Autor:
Ernest J. T. Luiten, Bea M D Lemaire, Elena M Ter Welle-Butalid, M. Wouter Dercksen, Birgit E.P.J. Vriens, Ron J. T. van Golde, Christine E. M. de Die-Smulders, Sandra L E Janssen-Engelen, Irene E. G. van Hellemond, Anne-Marie M G H van Riel, Josien G. Derhaag, Els R M van Haaren, Ingeborg J. H. Vriens, Marlène H W van de Poel, Agnes J. van de Wouw, Ester E M Schepers-van der Sterren, Maaike de Boer, Sandra M. E. Geurts, Vivianne C. G. Tjan-Heijnen
Publikováno v:
Breast Cancer Research and Treatment, 181(1), 77-86. Springer, Cham
Purpose We assessed the uptake of fertility preservation (FP), recovery of ovarian function (OFR) after chemotherapy, live birth after breast cancer, and breast cancer outcomes in women with early-stage breast cancer. Methods Women aged below 41 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf9315f1cd82567764d4f6278c9cfbbb
https://cris.maastrichtuniversity.nl/en/publications/4ff9839f-07a5-47de-a765-f134656cb5cf
https://cris.maastrichtuniversity.nl/en/publications/4ff9839f-07a5-47de-a765-f134656cb5cf
Autor:
Adri C. Voogd, Maaike de Boer, Shanly C. Seferina, M. Wouter Dercksen, Bram Ramaekers, Vivianne C.G. Tjan Heijnen, Agnes J. van de Wouw, Roel J.W. van Kampen, Franchette W P J van den Berkmortel, Manuela A. Joore
Publikováno v:
Oncotarget
Oncotarget, 8(45), 79223-79233. Impact Journals LLC
Oncotarget, 8(45), 79223-79233. Impact Journals LLC
// Shanly C. Seferina 1,2 , Bram L.T. Ramaekers 8 , Maaike de Boer 1,2 , M. Wouter Dercksen 3 , Franchette van den Berkmortel 4 , Roel J.W. van Kampen 1,5 , Agnes J. van de Wouw 6 , Adri C. Voogd 1,2,7 , Vivianne C.G. Tjan Heijnen 1,2 , Manuela A. Jo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::430b4bfabf9195c77c37b341669d15d8
https://doi.org/10.18632/oncotarget.16985
https://doi.org/10.18632/oncotarget.16985
Autor:
Martijn P. Lolkema, Marco B. Polee, Olaf Loosveld, Paul Hamberg, Geert A. Cirkel, Stefan Sleijfer, Heinz-Josef Klümpen, Johanna E.A. Portielje, Emile E. Voest, Frank P. J. Peters, Vincent van der Noort, Gerard Groenewegen, Maartje Los, Maureen J.B. Aarts, Franchette W P J van den Berkmortel, Laurens V. Beerepoot, John B. A. G. Haanen, Metin Tascilar, M. Wouter Dercksen
Publikováno v:
JAMA oncology, 3(4), 501-508. American Medical Association
JAMA Oncology, 3(4), 501-508. American Medical Association
JAMA Oncology, 3(4), 501-508. American Medical Association
Importance To our knowledge, this is the first randomized clinical trial evaluating an alternating treatment regimen in an attempt to delay disease progression in clear cell renal cell carcinoma. Objective To test our hypothesis that an 8-week rotati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89bbf142a6a895c6a5a76a5f47e71e11
https://doi.org/10.1001/jamaoncol.2016.5202
https://doi.org/10.1001/jamaoncol.2016.5202
Autor:
Jacobus J M van der Hoeven, Saskia van de Ven, Hein Putter, Gerrit-Jan Liefers, Marta Fiocco, Judith R. Kroep, LW Kessels, A. Charehbili, Johan W. R. Nortier, Birgit E.P.J. Vriens, Elma Meershoek-Klein Kranenbarg, Joan B. Heijns, M. Wouter Dercksen, Vincent T.H.B.M. Smit, Stefanie de Groot, Hanno Pijl, MJ Pepels, Hanneke W. M. van Laarhoven, Laurence J. C. van Warmerdam
Publikováno v:
Breast Cancer Research, 21(1)
Breast Cancer Research, 21, 1
Breast Cancer Research, Vol 21, Iss 1, Pp 1-9 (2019)
Breast cancer research, 21(1):97. BioMed Central
Breast Cancer Research, 21
Breast Cancer Research : BCR
Breast Cancer Research, 21(1). BioMed Central
Breast Cancer Research, 21, 1
Breast Cancer Research, Vol 21, Iss 1, Pp 1-9 (2019)
Breast cancer research, 21(1):97. BioMed Central
Breast Cancer Research, 21
Breast Cancer Research : BCR
Breast Cancer Research, 21(1). BioMed Central
Background Adjuvant bisphosphonates are associated with improved breast cancer survival in postmenopausal patients. Addition of zoledronic acid (ZA) to neoadjuvant chemotherapy did not improve pathological complete response in the phase III NEOZOTAC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ea7e16c671ab5a7dc8cb40a3a83c899
https://doi.org/10.1186/s13058-019-1180-6
https://doi.org/10.1186/s13058-019-1180-6